Galleri® multi-cancer early detection test

At Priority Health we know that early detection is a priority.  That’s why we’re the first Medicare Advantage plan in Michigan to offer the Galleri® multi-cancer early detection test from GRAIL1.  While today doctors screen individually for 5 specific cancers, nearly 70% of cancers have no recommended screening test.2,3 The Galleri test aims to change that.

The Galleri test is the first-of-its-kind and is available on our 2025 Wellness plans.

  • A proactive blood test that screens for many deadly cancers before symptoms appear
  • Screens for a unique “fingerprint” of 50+ cancers, including many without recommended screening available today
  • Predicts the most likely origin of the cancer signal, to help healthcare providers guide the next steps for diagnosis
  • Added to recommended cancer screenings, the Galleri test helps you do more to screen for cancer

Do more to screen for cancer.

Join the PriorityMedicareSM Thrive and Thrive Plus plans and add the Galleri test to your recommended screenings.  The Galleri test is accessible with a copay starting in January 2025 to eligible Priority Health Medicare Advantage plan members.

The Galleri test is available to members on the PriorityMedicare Thrive and PriorityMedicare Thrive Plus plans that meet eligibility requirements.

Galleri is a registered trademark of GRAIL,LLC.

1The Galleri test is available by prescription only. Galleri does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test identifies DNA in the bloodstream shed by cancer cells and does not predict future genetic risk for cancer. The Galleri test should be used in addition to healthcare provider recommended screening tests. Eligibility rules apply.

2American Cancer Society. Cancer facts & figures 2022. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html [GRAIL, LLC. Data on file: GA-2021-0065]. 

3 Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2017 Sub. Includes persons aged 50+ diagnosed 2006-2015. [GRAIL, LLC. Data on file: GA-2021-0065.]